aim
vinegarbak
radix
bupleuri
vbrb
potenti
activ
anticanc
drug
liver
increas
hepat
distribut
howev
phenomenon
may
associ
drug
transport
investig
effect
saikosaponin
main
compon
vbrb
activ
express
differ
drug
transport
normal
cell
overexpress
transport
main
method
activ
transport
analyz
concentr
cellular
substrat
concentr
colchicin
substrat
pgp
cisplatin
substrat
determin
highperform
liquid
chromatographi
hplc
concentr
rhodamin
b
determin
flow
cytometri
express
transport
gene
protein
determin
qrtpcr
western
blot
analysi
key
find
increas
colchicin
efflux
cell
primarili
increas
activ
independ
gene
protein
express
enhanc
function
increas
cisplatin
efflux
cell
upregul
gene
express
margin
effect
pgp
normal
cell
increas
activ
cell
increas
express
protein
mrna
howev
inhibit
activ
cell
decreas
protein
express
decreas
pgp
activ
pgpand
cell
signific
might
potenti
key
activ
compon
vbrb
enhanc
hepatotarget
anticanc
drug
inhibit
multidrug
resistanceassoci
drug
transport
pgp
environmentdepend
manner
convent
cancer
chemotherapeut
induc
system
side
effect
poor
local
select
tumortarget
drug
high
efficaci
select
found
widespread
applic
treatment
tumor
howev
high
cost
treatment
poor
biocompat
limit
tumortarget
therapi
develop
safe
effect
anticanc
drug
therefor
key
clinic
imper
tradit
chines
medicin
medicin
guid
herb
use
enhanc
effect
chemotherapeut
agent
compar
target
drug
deliveri
approach
simpl
safe
econom
howev
lack
understand
mechan
action
underli
effect
approach
limit
wider
applic
develop
vbrb
vinegarbak
product
radix
bupleuri
dri
radix
bupleurum
chines
dc
bupleurum
scozonerifolium
medicin
hepatotarget
herb
studi
cheung
et
al
vbrb
shown
increas
efficaci
anticanc
drug
patient
unresect
hepatocellular
carcinoma
previou
studi
vbrb
show
good
hepatotarget
effici
increas
distribut
rhein
oxymatrin
resveratrol
liver
rat
mice
find
suggest
vbrb
potenti
hepat
drug
concentr
although
specif
vbrb
compon
respons
hepatotarget
effect
mechan
action
known
differ
type
compound
includ
saikosaponin
c
polysaccharid
lignin
volatil
oil
vbrb
recent
studi
identifi
saikosaponin
princip
activ
compon
vbrb
explor
activ
nativ
saponin
saikosaponin
c
howev
research
suggest
secondari
saponin
saikosaponin
nativ
saponin
saikosaponin
c
main
compon
vbrb
radix
bupleuri
vbrb
mainli
use
treatment
hepat
diseas
indic
previou
studi
effect
vbrb
may
associ
drug
transport
hepat
cell
previou
studi
found
hepatoprotect
effect
vbrb
enhanc
content
saikosaponin
increas
higher
concentr
vinegar
use
process
overal
studi
indic
saikosaponin
may
play
key
role
enhanc
hepatotarget
effect
vbrb
chang
tissu
drug
distribut
modul
complex
interplay
factor
cell
signal
transduct
pathway
drug
transport
one
key
player
studi
explor
effect
saikosaponin
activ
express
pglycoprotein
pgp
multiresistancerel
protein
organ
cation
transport
cell
normal
express
overexpress
transport
cell
obtain
american
type
cultur
collect
atcc
manassa
va
usa
cell
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
grand
island
usa
supplement
fetal
bovin
serum
fb
penicillinstreptomycin
mixtur
gibco
grand
island
usa
glutathion
gsh
stimul
cell
model
establish
addit
gsh
mm
stimul
stabl
overexpress
pgp
cell
establish
lentivir
vector
accord
previous
describ
protocol
saikosaponin
puriti
purchas
winherb
medic
technolog
fig
shanghai
china
pgp
mous
monoclon
antibodi
antimous
immunoglobulin
g
igg
horseradish
peroxidas
hrp
conjug
antibodi
purchas
abcam
cambridg
uk
gapdh
antibodi
purchas
cell
signal
technolog
usa
bca
protein
assay
kit
reagent
purchas
invitrogen
carlsbad
us
revert
aid
first
strand
cdna
synthesi
color
flash
green
qpcr
kit
obtain
thermofish
scientif
rockford
us
colchicin
cisplatin
rhodamin
b
verapamil
bromid
mtt
purchas
sigmaaldrich
st
loui
mo
us
chemic
commerci
avail
reagent
grade
cell
seed
plate
cell
densiti
cell
per
well
respect
incub
h
thereaft
cell
treat
differ
concentr
saikosaponin
h
subsequ
mtt
gl
ad
cell
incub
h
formazan
form
cultur
medium
remov
dmso
ad
dissolv
formazan
optic
densiti
measur
nm
cisplatin
colchicin
uptak
assay
cell
seed
sixwel
plate
saikosaponin
andor
transport
inhibitor
verapamil
ad
incub
h
subsequ
cell
treat
cisplatin
h
colchicin
h
cell
harvest
lyse
freezethaw
method
three
time
cell
lysat
centrifug
supernat
collect
subject
highperform
liquid
chromatographi
hplc
analysi
thereaft
separ
conduct
use
diamonsil
column
mm
mobil
phase
water
methanol
acetonitril
flow
rate
cisplatin
water
methanol
flow
rate
colchicin
detect
wavelength
nm
respect
total
protein
concentr
determin
use
bca
protein
assay
kit
accord
manufactur
instruct
substrat
uptak
express
cisplatinmg
protein
colchicinemg
protein
rhodamin
b
uptak
assay
cell
treat
saikosaponin
h
thereaft
cultur
medium
discard
nm
rhodamin
b
ad
min
incub
dark
cell
harvest
flow
cytometri
cellstim
detect
rel
fluoresc
intens
intracellular
rhodamin
b
treatment
saikosaponin
h
cell
harvest
lyse
ripa
buffer
contain
proteas
inhibitor
protein
concentr
determin
bca
protein
assay
kit
equal
amount
protein
separ
sdspage
membran
transfer
block
membran
treat
primari
antibodi
pgp
overnight
incub
hrplink
antirabbit
igg
h
room
temperatur
use
ecl
develop
immunoreact
band
expos
kodak
medic
xray
film
intens
analyz
gel
xr
quantiti
analysi
softwar
biorad
laboratori
richmond
ca
us
normal
gapdh
express
sampl
treatment
saikosaponin
b
cell
harvest
total
rna
extract
reagent
use
total
rna
templat
cdna
synthesi
synthes
first
strand
cdna
use
revert
aid
first
strand
cdna
synthesi
kit
accord
manufactur
protocol
cdna
use
q
rtpcr
togeth
primer
list
tabl
amplif
reaction
undertaken
use
abi
realtim
pcr
machin
appli
biosystem
usa
follow
condit
denatur
min
follow
cycl
min
ct
method
use
data
analysi
experi
conduct
triplic
result
express
mean
standard
deviat
sd
data
process
analysi
undertaken
spss
softwar
independ
sampl
ttest
use
pairwis
comparison
wherea
fisher
least
signific
differ
lsd
test
use
multipl
comparison
p
p
consid
indic
statist
signific
mtt
assay
investig
effect
saikosaponin
viabil
cell
cell
surviv
concentr
respect
therefor
use
two
concentr
subsequ
experi
colchicin
use
studi
activ
pgp
substrat
transport
exclud
interfer
ad
inhibitor
pgp
inhibitor
verapamil
treatment
cell
saikosaponin
colchicin
uptak
decreas
p
compar
control
group
fig
howev
h
addit
inhibitor
verapamil
inhibitor
significantli
increas
colchicin
uptak
p
result
indic
pgp
contribut
colchicin
efflux
compar
verapamilcontrol
group
treatment
saikosaponin
decreas
colchicin
uptak
p
fig
howev
saikosaponin
show
signific
effect
compar
group
fig
furthermor
studi
effect
saikosaponin
pgp
protein
mrna
level
saikosaponin
margin
effect
pgp
fig
e
fig
g
protein
mrna
respect
find
indic
saikosaponin
decreas
accumul
colchicin
cell
mainli
increas
activ
cisplatin
platinumbas
drug
substrat
therefor
investig
effect
saikosaponin
activ
detect
accumul
cisplatin
cell
treatment
saikosaponin
cisplatin
accumul
decreas
p
fig
subsequ
determin
protein
mrna
express
studi
underli
mechan
saikosaponin
remark
effect
protein
mrna
express
fig
furthermor
saikosaponin
notabl
effect
protein
howev
increas
mrna
express
fig
e
result
indic
saikosaponin
hamper
cisplatin
uptak
normal
cell
mainli
increas
gene
express
treatment
cell
saikosaponin
increas
cisplatin
uptak
p
fig
protein
mrna
express
increas
p
p
respect
result
indic
saikosaponin
increas
activ
proteinand
genedepend
manner
cell
saikosaponin
increas
uptak
cisplatin
p
wherea
inhibitor
increas
uptak
cisplatin
p
fig
protein
express
decreas
treatment
saikosaponin
respect
p
fig
c
rhodamin
b
substrat
pgp
shown
fig
rel
fluoresc
rhodamin
b
decreas
significantli
p
cell
compar
vector
follow
addit
saikosaponin
verapamil
pgp
inhibitor
cell
rel
fluoresc
rhodamin
b
significantli
increas
p
respect
result
indic
saikosaponin
inhibit
pgp
activ
pgp
overexpress
effect
stronger
verapamil
howev
examin
effect
saikosaponin
overexpress
construct
gshstimul
cell
model
gshdepend
protein
stimul
gsh
uptak
colchicin
cell
significantli
declin
gene
protein
express
notabl
increas
p
p
addit
inhibitor
colchicin
uptak
increas
p
wherea
gene
protein
express
decreas
p
p
fig
respect
data
indic
success
establish
cell
model
treatment
saikosaponin
increas
colchicin
uptak
p
affect
protein
mrna
express
mani
year
medicin
target
herb
use
combin
antitumor
drug
treatment
tumor
chines
medicin
clinic
rational
use
medicin
target
herb
tumor
treatment
increas
distribut
antitumor
compound
target
tissu
vbrb
commonli
use
medicin
hepatotarget
herb
howev
activ
ingredi
vbrb
target
hepat
cell
underli
mechan
action
well
character
drug
transport
determin
tissu
distribut
amen
modul
foreign
substanc
activ
ingredi
medicin
target
drug
may
serv
induc
inhibitor
transport
may
modifi
tissu
distribut
drug
although
saikosaponin
index
compon
radix
bupleuri
nativ
saponin
transform
secondari
saponin
saikosaponin
process
decoct
vinegar
saikosaponin
rel
stabl
saikosaponin
consid
index
compon
vbrb
howev
limit
report
regard
bioactiv
studi
shown
vbrb
good
inhibitori
effect
human
corona
viru
e
addit
vbrb
shown
inhibit
entri
hepat
c
viru
furthermor
saikosaponin
shown
inhibit
etoposideinduc
activ
melanoma
cell
expos
new
approach
overcom
cancer
chemoresist
moreov
shown
caus
igeinduc
mast
cell
degranul
relat
inflammatori
respons
best
knowledg
first
studi
document
effect
saikosaponin
drug
transport
inde
saikosaponin
may
activ
compon
respons
enhanc
hepatotarget
effect
vbrb
transport
transmembran
protein
facilit
movement
wide
varieti
substrat
across
membran
bilay
transport
respons
deliveri
nutrient
endogen
substanc
may
also
help
protect
endogen
exogen
toxic
function
transport
influenc
bodi
state
well
type
concentr
exogen
substanc
anticanc
therapi
typic
requir
long
durat
administr
given
safeti
key
concern
anticanc
therapi
studi
effect
saikosaponin
drug
transport
normal
cell
overexpress
transport
pgp
transport
ubiquit
express
abundantli
express
liver
especi
hepatocellular
carcinoma
cell
saikosaponin
margin
effect
pgp
activ
normal
state
howev
significantli
inhibit
pgp
activ
cell
find
suggest
coadministr
antitumor
drug
vbrb
may
lead
hepat
accumul
drug
therebi
exhibit
synergist
effect
toward
achiev
clinic
effect
less
gener
system
toxic
furthermor
normal
pgpoverexpress
cell
protein
gene
express
inconsist
activ
pgp
atpbind
cassett
transport
whose
function
depend
protein
mrna
level
also
relat
energi
suppli
variabl
hepat
nuclear
factor
studi
shown
certain
drug
modul
express
pgp
certain
cell
signal
pathway
kim
et
al
found
metformin
activ
ampk
suppress
express
cell
inhibit
activ
creb
seo
et
al
show
downregul
pgp
inhibit
pathway
may
amelior
multidrug
resist
studi
requir
determin
whether
saikosaponin
modul
function
pgp
via
signal
pathway
furthermor
studi
two
efflux
transport
relat
tumor
multidrug
resist
effect
saikosaponin
transport
similar
saikosaponin
enhanc
function
normal
cell
significantli
inhibit
activ
cell
cell
respect
normal
particip
detoxif
process
thu
enhanc
function
normal
state
help
avoid
harm
effect
exogen
compound
bodi
howev
high
express
level
lung
breast
ovarian
hepatocellular
carcinoma
cell
associ
unfavor
outcom
poor
prognosi
result
indic
saikosaponin
may
improv
therapeut
efficaci
antitumor
drug
multidrugresist
cancer
caus
overexpress
unlik
former
three
transport
influx
transport
mainli
transport
cation
compound
frequent
use
antitumor
drug
cisplatin
oxaliplatin
substrat
moreov
compensatori
renal
overexpress
demonstr
hepat
diseas
therefor
studi
effect
saikosaponin
normal
overexpress
condit
saikosaponin
enhanc
activ
overexpress
condit
upregul
mrna
protein
express
studi
indic
saikosaponin
may
aggrav
renal
toxic
platinumcontain
anticanc
drug
use
treatment
hepatocellular
carcinoma
saikosaponin
might
potenti
key
activ
ingredi
vbrb
enhanc
effect
hepatotarget
anticanc
drug
inhibit
multidrug
resistanceassoci
drug
transport
pgp
thu
saikosaponin
enhanc
effici
chemotherapi
drug
prevent
develop
multidrug
resist
hepatocellular
carcinoma
howev
use
platinumcontain
anticanc
drug
avoid
combin
saikosaponin
treatment
author
declar
conflict
interest
